Population pharmacokinetics of motexafin gadolinium in adults with brain metastases or glioblastoma multiforme.

MLA

Miles DR, et al. “Population Pharmacokinetics of Motexafin Gadolinium in Adults with Brain Metastases or Glioblastoma Multiforme.” Journal of Clinical Pharmacology, vol. 45, no. 3, Mar. 2005, pp. 299–312. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=106457572&authtype=sso&custid=ns315887.

APA

Miles DR, Smith JA, Phan S, Hutcheson SJ, Renschler MF, Ford JM, & Boswell GW. (2005). Population pharmacokinetics of motexafin gadolinium in adults with brain metastases or glioblastoma multiforme. Journal of Clinical Pharmacology, 45(3), 299–312.

Chicago

Miles DR, Smith JA, Phan S, Hutcheson SJ, Renschler MF, Ford JM, and Boswell GW. 2005. “Population Pharmacokinetics of Motexafin Gadolinium in Adults with Brain Metastases or Glioblastoma Multiforme.” Journal of Clinical Pharmacology 45 (3): 299–312. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=106457572&authtype=sso&custid=ns315887.